DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3鈥� carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
The global Sanger Sequencing Service market size was valued at US$ 221 million in 2023 and is forecast to a readjusted size of USD 218 million by 2030 with a CAGR of -0.1% during review period.
Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.
This report is a detailed and comprehensive analysis for global Sanger Sequencing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Sanger Sequencing Service market size and forecasts, in consumption value ($ Million), 2019-2030
Global Sanger Sequencing Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Sanger Sequencing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Sanger Sequencing Service market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sanger Sequencing Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sanger Sequencing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Azenta, Eurofins Scientific, LGC Biosearch Technologies, Fasteris, QuintaraBio, Laragen, Microsynth, Nucleics, GenScript Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Sanger Sequencing Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Sanger Sequencing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others
Market segment by Application
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others
Market segment by players, this report covers
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Sanger Sequencing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sanger Sequencing Service, with revenue, gross margin, and global market share of Sanger Sequencing Service from 2019 to 2024.
Chapter 3, the Sanger Sequencing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sanger Sequencing Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sanger Sequencing Service.
Chapter 13, to describe Sanger Sequencing Service research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sanger Sequencing Service by Type
1.3.1 Overview: Global Sanger Sequencing Service Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Sanger Sequencing Service Consumption Value Market Share by Type in 2023
1.3.3 PCR Products
1.3.4 Plasmid DNA
1.3.5 Bacterial Artificial Chromosomes (BAC)
1.3.6 Others
1.4 Global Sanger Sequencing Service Market by Application
1.4.1 Overview: Global Sanger Sequencing Service Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Research Institutions
1.4.3 Biotech Companies
1.4.4 Universities and Colleges
1.4.5 Hospitals and Clinics
1.4.6 Pharmaceutical Companies
1.4.7 Others
1.5 Global Sanger Sequencing Service Market Size & Forecast
1.6 Global Sanger Sequencing Service Market Size and Forecast by Region
1.6.1 Global Sanger Sequencing Service Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Sanger Sequencing Service Market Size by Region, (2019-2030)
1.6.3 North America Sanger Sequencing Service Market Size and Prospect (2019-2030)
1.6.4 Europe Sanger Sequencing Service Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Sanger Sequencing Service Market Size and Prospect (2019-2030)
1.6.6 South America Sanger Sequencing Service Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Sanger Sequencing Service Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Sanger Sequencing Service Product and Solutions
2.1.4 Thermo Fisher Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Azenta
2.2.1 Azenta Details
2.2.2 Azenta Major Business
2.2.3 Azenta Sanger Sequencing Service Product and Solutions
2.2.4 Azenta Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Azenta Recent Developments and Future Plans
2.3 Eurofins Scientific
2.3.1 Eurofins Scientific Details
2.3.2 Eurofins Scientific Major Business
2.3.3 Eurofins Scientific Sanger Sequencing Service Product and Solutions
2.3.4 Eurofins Scientific Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Eurofins Scientific Recent Developments and Future Plans
2.4 LGC Biosearch Technologies
2.4.1 LGC Biosearch Technologies Details
2.4.2 LGC Biosearch Technologies Major Business
2.4.3 LGC Biosearch Technologies Sanger Sequencing Service Product and Solutions
2.4.4 LGC Biosearch Technologies Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 LGC Biosearch Technologies Recent Developments and Future Plans
2.5 Fasteris
2.5.1 Fasteris Details
2.5.2 Fasteris Major Business
2.5.3 Fasteris Sanger Sequencing Service Product and Solutions
2.5.4 Fasteris Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fasteris Recent Developments and Future Plans
2.6 QuintaraBio
2.6.1 QuintaraBio Details
2.6.2 QuintaraBio Major Business
2.6.3 QuintaraBio Sanger Sequencing Service Product and Solutions
2.6.4 QuintaraBio Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 QuintaraBio Recent Developments and Future Plans
2.7 Laragen
2.7.1 Laragen Details
2.7.2 Laragen Major Business
2.7.3 Laragen Sanger Sequencing Service Product and Solutions
2.7.4 Laragen Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Laragen Recent Developments and Future Plans
2.8 Microsynth
2.8.1 Microsynth Details
2.8.2 Microsynth Major Business
2.8.3 Microsynth Sanger Sequencing Service Product and Solutions
2.8.4 Microsynth Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Microsynth Recent Developments and Future Plans
2.9 Nucleics
2.9.1 Nucleics Details
2.9.2 Nucleics Major Business
2.9.3 Nucleics Sanger Sequencing Service Product and Solutions
2.9.4 Nucleics Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Nucleics Recent Developments and Future Plans
2.10 GenScript Biotech
2.10.1 GenScript Biotech Details
2.10.2 GenScript Biotech Major Business
2.10.3 GenScript Biotech Sanger Sequencing Service Product and Solutions
2.10.4 GenScript Biotech Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GenScript Biotech Recent Developments and Future Plans
2.11 CeMIA
2.11.1 CeMIA Details
2.11.2 CeMIA Major Business
2.11.3 CeMIA Sanger Sequencing Service Product and Solutions
2.11.4 CeMIA Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 CeMIA Recent Developments and Future Plans
2.12 StarSEQ
2.12.1 StarSEQ Details
2.12.2 StarSEQ Major Business
2.12.3 StarSEQ Sanger Sequencing Service Product and Solutions
2.12.4 StarSEQ Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 StarSEQ Recent Developments and Future Plans
2.13 Source BioScience
2.13.1 Source BioScience Details
2.13.2 Source BioScience Major Business
2.13.3 Source BioScience Sanger Sequencing Service Product and Solutions
2.13.4 Source BioScience Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Source BioScience Recent Developments and Future Plans
2.14 Guangzhou Life Technologies DaAn
2.14.1 Guangzhou Life Technologies DaAn Details
2.14.2 Guangzhou Life Technologies DaAn Major Business
2.14.3 Guangzhou Life Technologies DaAn Sanger Sequencing Service Product and Solutions
2.14.4 Guangzhou Life Technologies DaAn Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Guangzhou Life Technologies DaAn Recent Developments and Future Plans
2.15 SciGenom Labs
2.15.1 SciGenom Labs Details
2.15.2 SciGenom Labs Major Business
2.15.3 SciGenom Labs Sanger Sequencing Service Product and Solutions
2.15.4 SciGenom Labs Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 SciGenom Labs Recent Developments and Future Plans
2.16 Psomagen
2.16.1 Psomagen Details
2.16.2 Psomagen Major Business
2.16.3 Psomagen Sanger Sequencing Service Product and Solutions
2.16.4 Psomagen Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Psomagen Recent Developments and Future Plans
2.17 Tsingke Biotechnology
2.17.1 Tsingke Biotechnology Details
2.17.2 Tsingke Biotechnology Major Business
2.17.3 Tsingke Biotechnology Sanger Sequencing Service Product and Solutions
2.17.4 Tsingke Biotechnology Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Tsingke Biotechnology Recent Developments and Future Plans
2.18 GenHunter
2.18.1 GenHunter Details
2.18.2 GenHunter Major Business
2.18.3 GenHunter Sanger Sequencing Service Product and Solutions
2.18.4 GenHunter Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 GenHunter Recent Developments and Future Plans
2.19 CD Genomics
2.19.1 CD Genomics Details
2.19.2 CD Genomics Major Business
2.19.3 CD Genomics Sanger Sequencing Service Product and Solutions
2.19.4 CD Genomics Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 CD Genomics Recent Developments and Future Plans
2.20 Shanghai Personalbio Technology
2.20.1 Shanghai Personalbio Technology Details
2.20.2 Shanghai Personalbio Technology Major Business
2.20.3 Shanghai Personalbio Technology Sanger Sequencing Service Product and Solutions
2.20.4 Shanghai Personalbio Technology Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Shanghai Personalbio Technology Recent Developments and Future Plans
2.21 Suzhou Hongxun Biotechnologies
2.21.1 Suzhou Hongxun Biotechnologies Details
2.21.2 Suzhou Hongxun Biotechnologies Major Business
2.21.3 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Product and Solutions
2.21.4 Suzhou Hongxun Biotechnologies Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Suzhou Hongxun Biotechnologies Recent Developments and Future Plans
2.22 Guangzhou IGE Biotechnology
2.22.1 Guangzhou IGE Biotechnology Details
2.22.2 Guangzhou IGE Biotechnology Major Business
2.22.3 Guangzhou IGE Biotechnology Sanger Sequencing Service Product and Solutions
2.22.4 Guangzhou IGE Biotechnology Sanger Sequencing Service Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Guangzhou IGE Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Sanger Sequencing Service Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Sanger Sequencing Service by Company Revenue
3.2.2 Top 3 Sanger Sequencing Service Players Market Share in 2023
3.2.3 Top 6 Sanger Sequencing Service Players Market Share in 2023
3.3 Sanger Sequencing Service Market: Overall Company Footprint Analysis
3.3.1 Sanger Sequencing Service Market: Region Footprint
3.3.2 Sanger Sequencing Service Market: Company Product Type Footprint
3.3.3 Sanger Sequencing Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Sanger Sequencing Service Consumption Value and Market Share by Type (2019-2024)
4.2 Global Sanger Sequencing Service Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Sanger Sequencing Service Consumption Value Market Share by Application (2019-2024)
5.2 Global Sanger Sequencing Service Market Forecast by Application (2025-2030)
6 North America
6.1 North America Sanger Sequencing Service Consumption Value by Type (2019-2030)
6.2 North America Sanger Sequencing Service Market Size by Application (2019-2030)
6.3 North America Sanger Sequencing Service Market Size by Country
6.3.1 North America Sanger Sequencing Service Consumption Value by Country (2019-2030)
6.3.2 United States Sanger Sequencing Service Market Size and Forecast (2019-2030)
6.3.3 Canada Sanger Sequencing Service Market Size and Forecast (2019-2030)
6.3.4 Mexico Sanger Sequencing Service Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Sanger Sequencing Service Consumption Value by Type (2019-2030)
7.2 Europe Sanger Sequencing Service Consumption Value by Application (2019-2030)
7.3 Europe Sanger Sequencing Service Market Size by Country
7.3.1 Europe Sanger Sequencing Service Consumption Value by Country (2019-2030)
7.3.2 Germany Sanger Sequencing Service Market Size and Forecast (2019-2030)
7.3.3 France Sanger Sequencing Service Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Sanger Sequencing Service Market Size and Forecast (2019-2030)
7.3.5 Russia Sanger Sequencing Service Market Size and Forecast (2019-2030)
7.3.6 Italy Sanger Sequencing Service Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Sanger Sequencing Service Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Sanger Sequencing Service Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Sanger Sequencing Service Market Size by Region
8.3.1 Asia-Pacific Sanger Sequencing Service Consumption Value by Region (2019-2030)
8.3.2 China Sanger Sequencing Service Market Size and Forecast (2019-2030)
8.3.3 Japan Sanger Sequencing Service Market Size and Forecast (2019-2030)
8.3.4 South Korea Sanger Sequencing Service Market Size and Forecast (2019-2030)
8.3.5 India Sanger Sequencing Service Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Sanger Sequencing Service Market Size and Forecast (2019-2030)
8.3.7 Australia Sanger Sequencing Service Market Size and Forecast (2019-2030)
9 South America
9.1 South America Sanger Sequencing Service Consumption Value by Type (2019-2030)
9.2 South America Sanger Sequencing Service Consumption Value by Application (2019-2030)
9.3 South America Sanger Sequencing Service Market Size by Country
9.3.1 South America Sanger Sequencing Service Consumption Value by Country (2019-2030)
9.3.2 Brazil Sanger Sequencing Service Market Size and Forecast (2019-2030)
9.3.3 Argentina Sanger Sequencing Service Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Sanger Sequencing Service Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Sanger Sequencing Service Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Sanger Sequencing Service Market Size by Country
10.3.1 Middle East & Africa Sanger Sequencing Service Consumption Value by Country (2019-2030)
10.3.2 Turkey Sanger Sequencing Service Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Sanger Sequencing Service Market Size and Forecast (2019-2030)
10.3.4 UAE Sanger Sequencing Service Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Sanger Sequencing Service Market Drivers
11.2 Sanger Sequencing Service Market Restraints
11.3 Sanger Sequencing Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Sanger Sequencing Service Industry Chain
12.2 Sanger Sequencing Service Upstream Analysis
12.3 Sanger Sequencing Service Midstream Analysis
12.4 Sanger Sequencing Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology
听
听
*If Applicable.
